Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,909 | 5,720 | 6,748 | 11,628 | 19,760 |
| Receivables | 413 | 50 | 37 | 156 | 110 |
| TOTAL | $84,310 | $5,987 | $6,813 | $11,948 | $20,038 |
| Non-Current Assets | |||||
| PPE Net | 112 | 118 | 66 | 139 | N/A |
| Intangibles | N/A | N/A | N/A | 0 | 2 |
| TOTAL | $112 | $118 | $66 | $139 | $2 |
| Total Assets | $84,422 | $6,105 | $6,879 | $12,087 | $20,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,710 | 408 | 182 | 1,246 | 597 |
| Accrued Expenses | 541 | 42 | 25 | 158 | 42 |
| TOTAL | $2,335 | $529 | $281 | $1,472 | $639 |
| Non-Current Liabilities | |||||
| TOTAL | $41 | $40 | $0 | $72 | $0 |
| Total Liabilities | $2,377 | $568 | $281 | $1,544 | $639 |
| Shareholders' Equity | |||||
| Common Shares | 123,250 | 35,423 | 33,914 | 32,238 | 27,080 |
| Retained earnings | -46,578 | -34,349 | -31,547 | -24,175 | -9,210 |
| Other shareholders' equity | 5,373 | 4,462 | 4,231 | 2,479 | 1,531 |
| TOTAL | $82,045 | $5,536 | $6,598 | $10,543 | $19,402 |
| Total Liabilities And Equity | $84,422 | $6,105 | $6,879 | $12,087 | $20,040 |